Pharmacophore-Based Discovery of New Human Dihydroorotate Dehydrogenase Inhibitor

E-ISSN： 1875-6638|10|4|402-408

ISSN： 1573-4064

Source： Medicinal Chemistry, Vol.10, Iss.4, 2014-04, pp. : 402-408

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Current κ Opioid Receptor Ligands and Discovery of a New Molecular Scaffold as a κ Opioid Receptor Antagonist Using Pharmacophore-Based Virtual Screening

Current Pharmaceutical Design, Vol. 19, Iss. 42, 2013-12 ,pp. : 7362-7372

Bentham Science Publishers

Access to resources Recommend Favorite

Pharmacophore-Based Virtual Screening

Current Medicinal Chemistry, Vol. 15, Iss. 10, 2008-04 ,pp. : 1018-1024

Bentham Science Publishers

Access to resources Recommend Favorite

Evaluation of WO2013076170: the use of a dihydroorotate dehydrogenase inhibitor for the treatment of psoriasis

By Norman Peter

Expert Opinion on Therapeutic Patents, Vol. 23, Iss. 10, 2013-10 ,pp. : 1391-1394

Informa Healthcare

Access to resources Recommend Favorite

Ligand and Structure-Based Pharmacophore Modeling for the Discovery of Potential Human HNMT Inhibitors

Letters in Drug Design & Discovery, Vol. 9, Iss. 1, 2012-01 ,pp. : 17-29

Bentham Science Publishers

Access to resources Recommend Favorite

In Vitro and Pharmacophore-Based Discovery of Novel hPEPT1 Inhibitors

By Ekins Sean Johnston Jeffrey S. Bahadduri Praveen D’Souza Vanessa M. Ray Abhijit Chang Cheng Swaan Peter W.

Pharmaceutical Research, Vol. 22, Iss. 4, 2005-04 ,pp. : 512-517

Springer Publishing Company

Access to resources Recommend Favorite